BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32372313)

  • 21. Proceedings of a workshop: bridging the gap in care and addressing participation in clinical trials.
    Bleyer A; Morgan S; Barr R
    Cancer; 2006 Oct; 107(7 Suppl):1656-8. PubMed ID: 16906509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASO Author Reflections: Current Issues in Conduct and Reporting of Noninferiority Randomized Controlled Trials in the Surgical Management of Cancer Patients.
    Marini W; Moher D; McCready D; Parsyan A
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):751-752. PubMed ID: 32436188
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Tumor Sidedness in CRS/IPC.
    Yuval JB; Adileh M; Cercek A; Nash GM
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):907-908. PubMed ID: 32845418
    [No Abstract]   [Full Text] [Related]  

  • 24. ASO Author Reflections: Breast Cancer Screening in the Safety-Net: Trying to Close the Gap When the Fault Lines Go Deep.
    Ahmadiyeh N
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):684-685. PubMed ID: 32712890
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: Clarifying the Controversy Generated by Non-inferiority Trials of Laparoscopic Surgery for Rectal Cancer.
    Acuna SA; Chesney TR; Baxter NN
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):545-546. PubMed ID: 30556114
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.
    Castelo M; Scheer AS
    Ann Surg Oncol; 2020 Aug; 27(8):2677-2678. PubMed ID: 32206953
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology.
    Garas G
    Ann Surg Oncol; 2018 Dec; 25(13):3889-3890. PubMed ID: 30238245
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Radiopathomics Strategy of Combing Multi-scale Tumor Information on Pretreatment to Predict the Pathologic Response to Neoadjuvant Therapy.
    Tian J; Fan X; Xu R; Sun YS; Yang G
    Ann Surg Oncol; 2020 Oct; 27(11):4307-4308. PubMed ID: 32495287
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: From Concept to Real Clinical Practice of Laparoscopic Distal Pancreatectomy for Left-Sided Pancreatic Cancer.
    Kang CM
    Ann Surg Oncol; 2020 Dec; 27(13):5237-5238. PubMed ID: 32462529
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis.
    Kawaguchi Y; Vauthey JN
    Ann Surg Oncol; 2020 Oct; 27(11):4271-4272. PubMed ID: 32642998
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: Utilizing National Databases to Identify Areas of Future Focus When Studying Rare Tumors.
    Ruff SM; DePeralta DK
    Ann Surg Oncol; 2021 Dec; 28(13):8329. PubMed ID: 34319476
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Reflections: How Should a Surgeon Care and Manage Cancer Metastasis?
    Zhang X; Li TS
    Ann Surg Oncol; 2020 Apr; 27(4):1075-1076. PubMed ID: 31832918
    [No Abstract]   [Full Text] [Related]  

  • 33. ASO Author Reflections: Disparities in Colon Cancer Outcomes Exist Irrespective of Hospital Performance-System-Wide Changes Are Needed to Help Close the Gap.
    Buchheit JT; Merkow RP
    Ann Surg Oncol; 2024 Feb; 31(2):1091-1092. PubMed ID: 38082169
    [No Abstract]   [Full Text] [Related]  

  • 34. ASO Author Reflections: The National Cancer Database as a Tool to Advance the Quality of Cancer Care Delivery in the US.
    Mallin K
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):623-624. PubMed ID: 31144138
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: A Novel Tool to Assess and Describe HIPEC Complications.
    Dumitra S; Lee B
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):557-558. PubMed ID: 30600405
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Improved Survival for Stage IV Breast Cancer: Considerations for Surgery in the Era of HER2-Targeted Therapy.
    Mudgway R; Lum SS
    Ann Surg Oncol; 2020 Aug; 27(8):2721-2722. PubMed ID: 32170478
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Palliative Care and Aggressive End-of-Life Care: A Surgeon's Reflections on Priorities for the Future.
    Merchant SJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):618-619. PubMed ID: 30298315
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: Real Prevalence of Occult Cancer Cells in Peritoneal Lavage in Patients with Pancreatic Ductal Adenocarcinoma.
    Suenaga M; Fujii T
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):893-894. PubMed ID: 32812111
    [No Abstract]   [Full Text] [Related]  

  • 39. ASO Author Reflections: Equitable High-Quality Cancer Surgery Care: Optimism, Pessimism, and Realism.
    Wasif N
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):614-615. PubMed ID: 30244422
    [No Abstract]   [Full Text] [Related]  

  • 40. ASO Author Reflections: Prognostic Factors in Gastrointestinal Extrapulmonary Small Cell Carcinoma Using Real-World Data.
    Ulanja MB; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Alese OB
    Ann Surg Oncol; 2022 Dec; 29(13):8261-8262. PubMed ID: 36006493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.